Square Pharmaceuticals’ Chairman Samuel S Chowdhury has announced that he will buy 20 lakh shares of the company at the prevailing market price, according to a disclosure filed with the Dhaka Stock Exchange (DSE) today (20 January).
Under the plan, the shares, worth Tk43 crore with each costing Tk215.20, will be acquired from both the public market and through block transactions on the DSE within the next 30 working days.
Samuel Chowdhury already holds a significant stake in the company – 8.42 shares until June 2025 – and this latest planned purchase underscores the continued confidence of senior leadership in Square Pharma’s long-term prospects.
Keep updated, follow The Business Standard’s Google news channelEarlier this month, in a separate disclosures, Square Pharmaceuticals Managing Director Tapan Chowdhury, and Director Ratna Patra also announced plans to buy a total 30 lakh shares – with Tapan purchasing 20 lakh shares and Ratna 10 lakh – of the company at the market price within the next 30 working days.
Until June 2025, Tapan held 8.55 crore shares and Ratna 7.95 crore shares of Square Pharmaceuticals.
Industry data shows that sponsor-directors of Square Pharmaceuticals have been steadily increasing their holdings, a trend often viewed by market observers as a sign of confidence in the company’s future performance.
Square Pharmaceuticals is currently the second-largest listed company on the DSE by market capitalisation, valued at around Tk18,500 crore, which represents roughly 5.6% of the total market capitalisation of the bourse.
According to the company’s December shareholding statement, sponsors and directors jointly hold a combined 43.59% of the company’s shares, institutional investors own 14.54%, foreign investors 14.52%, and general investors account for the remaining 27.35%.
https://www.tbsnews.net/economy/stocks/square-pharma-chairman-buy-20-lakh-shares-worth-tk43cr-1339501
